Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vogels

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Arthritis and Rheumatism|February 24, 2001
The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissueP H Goossens, R Vogels, E Pieterman, et al.
Journal of Virology|March 10, 2001
Improved adenovirus vectors for infection of cardiovascular tissuesM J Havenga, A A Lemckert, J M Grimbergen, et al.
Mechanisms of Development|March 1, 1991
The mouse homeobox gene, S8, is expressed during embryogenesis predominantly in mesenchymeD J Opstelten, R Vogels, B Robert, et al.
Human Gene Therapy|January 20, 1996
Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumorsA J Vincent, R Vogels, G V Someren, et al.
Vaccine|May 12, 2009
Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse geneticsW Koudstaal, L Hartgroves, M Havenga, et al.
Biotechnology and Bioengineering|June 3, 2008
Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivityM J E Havenga, L Holterman, I Melis, et al.
Vaccine|January 26, 2007
A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cellsG Marzio, E Kerkvliet, J A Bogaards, et al.
The Journal of General Virology|July 19, 2006
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cellsM Havenga, R Vogels, D Zuijdgeest, et al.
Journal of Virology|April 5, 2002
Exploiting the natural diversity in adenovirus tropism for therapy and prevention of diseaseM J E Havenga, A A C Lemckert, O J A E Ophorst, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Arthritis and Rheumatism|February 24, 2001
The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissueP H Goossens, R Vogels, E Pieterman, et al.
Journal of Virology|March 10, 2001
Improved adenovirus vectors for infection of cardiovascular tissuesM J Havenga, A A Lemckert, J M Grimbergen, et al.
Mechanisms of Development|March 1, 1991
The mouse homeobox gene, S8, is expressed during embryogenesis predominantly in mesenchymeD J Opstelten, R Vogels, B Robert, et al.
Human Gene Therapy|January 20, 1996
Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumorsA J Vincent, R Vogels, G V Someren, et al.
Vaccine|May 12, 2009
Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse geneticsW Koudstaal, L Hartgroves, M Havenga, et al.
Biotechnology and Bioengineering|June 3, 2008
Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivityM J E Havenga, L Holterman, I Melis, et al.
Vaccine|January 26, 2007
A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cellsG Marzio, E Kerkvliet, J A Bogaards, et al.
The Journal of General Virology|July 19, 2006
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cellsM Havenga, R Vogels, D Zuijdgeest, et al.
Journal of Virology|April 5, 2002
Exploiting the natural diversity in adenovirus tropism for therapy and prevention of diseaseM J E Havenga, A A C Lemckert, O J A E Ophorst, et al.
Pageof 8